Risk of atrial fibrillation in diabetes mellitus: A nationwide cohort study

European Journal of Preventive Cardiology

Volumn 23, Issue 6, 2016, Pages 621-627

  Pallisgaard, Jannik L ^a,b,d   Schjerning, Anne Marie ^a   Lindhardt, Tommi B ^a   Procida, Kristina ^c   Hansen, Morten L ^a   Torp Pedersen, Christian ^d,e   Gislason, Gunnar H ^a,b,f,g  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c HILLERØD HOSPITAL   (Denmark)

^d Mental Health Center Glostrup   (Denmark)

^e AALBORG UNIVERSITY   (Denmark)

^f UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^g Danish Heart Foundation   (Denmark)

Author keywords

Atrial fibrillation; diabetes mellitus; stroke; young patients

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; ATRIAL FIBRILLATION; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POPULATION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX ALLOCATION; ADOLESCENT; AGE; AGED; DENMARK; MIDDLE AGED; REGISTER; SEX DIFFERENCE; TIME FACTOR; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; COMORBIDITY; DENMARK; DIABETES MELLITUS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 84959915456     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487315599892     Document Type: Article

References (39)

1. Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study. Circulation 2014; 129 (8): 837-847. doi: CIRCULATIONAHA.113.005119.
2. Camm AJ, Kirchhof P, Lip GYH, et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31: 2369-2429.
3. Kristensen SL, Lindhardsen J, Ahlehoff O, et al. Increased risk of atrial fibrillation and stroke during active stages of inflammatory bowel disease: a nationwide study. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol 2014; 16: 477-484.
4. Ahlehoff O, Gislason GH, Jørgensen CH, et al. Psoriasis and Risk of Atrial Fibrillation and Ischaemic Stroke: A Danish Nationwide Cohort Study. Eur Heart J [Internet]. 2011 [cited 2012 May 16]; Available from: http://eurheartj.oxfordjournals.org/content/early/2011/08/25/eurheartj.ehr285.
5. Camm AJ, Lip GYH, Caterina RD, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation. An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Europace 2012; 14: 1385-1413.
6. Benjamin EJ, Levy D, Vaziri SM, et al. Independent Risk Factors for Atrial Fibrillation in a Population-Based Cohort: The Framingham Heart Study. JAMA J Am Med Assoc 1994; 271: 840-844.
7. Dublin S, Glazer N, Smith N, et al. Diabetes mellitus, glycemic control, and risk of atrial fibrillation. J Gen Intern Med 2010; 25: 853-858.
8. Frost L, Hune LJ, Vestergaard P,. Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study. Am J Med 2005; 118: 489-495.
9. Johansen OE, Brustad E, Enger S, et al. Prevalence of abnormal glucose metabolism in atrial fibrillation: A case control study in 75-year old subjects. Cardiovasc Diabetol 2008; 7: 28-28.
10. Krahn AD, Manfreda J, Tate RB, et al. The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the Manitoba follow-up study. Am J Med 1995; 98: 476-484.
11. Movahed M-R, Hashemzadeh M, Mazen Jamal M,. Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. Int J Cardiol 2005; 105: 315-318.
12. Nichols GA, Reinier K, Chugh SS,. Independent contribution of diabetes to increased prevalence and incidence of atrial fibrillation. Diabetes Care 2009; 32: 1851-1856.
13. Rosengren A, Hauptman PJ, Lappas G, et al. Big men and atrial fibrillation: effects of body size and weight gain on risk of atrial fibrillation in men. Eur Heart J 2009; 30: 1113-1120.
14. Ruigómez A, Johansson S, Wallander M-A, et al. Incidence of chronic atrial fibrillation in general practice and its treatment pattern. J Clin Epidemiol 2002; 55: 358-363.
15. Smith J, Platonov P, Hedblad B, et al. Atrial fibrillation in the Malmö diet and cancer study: a study of occurrence, risk factors and diagnostic validity. Eur J Epidemiol 2010; 25: 95-102.
16. Watanabe H, Tanabe N, Watanabe T, et al. Metabolic Syndrome and Risk of Development of Atrial Fibrillation: The Niigata Preventive Medicine Study. Circulation. 2008; 117: 1255-1260.
17. Andersen TF, Madsen M, Jørgensen J, Mellemkjoer L, Olsen JH,. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999; 46: 263-268.
18. Schramm TK, Gislason GH, Køber L, et al. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people. Circulation 2008; 117: 1945-1954.
19. Olesen JB, Lip GYH, Hansen ML, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ [Internet]. 2011 [cited 2013 Jun 13]; 342. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3031123/.
20. Selmer C, Hansen ML, Olesen JB, et al. New-Onset Atrial Fibrillation Is a Predictor of Subsequent Hyperthyroidism: A Nationwide Cohort Study. PLoS ONE 2013; 8: e57893-e57893.
21. Rix TA, Riahi S, Overvad K, et al. Validity of the diagnoses atrial fibrillation and atrial flutter in a Danish patient registry. Scand Cardiovasc J 2012; 46: 149-153.
22. Huxley RR, Filion KB, Konety S, et al. Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation. Am J Cardiol 2011; 108: 56-62.
23. Aksnes TA, Schmieder RE, Kjeldsen SE, et al. Impact of new-onset diabetes mellitus on development of atrial fibrillation and heart failure in high-risk hypertension (from the VALUE Trial). Am J Cardiol 2008; 101: 634-638.
24. Östgren CJ, Merlo J, Råstam L, et al. Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community. Diabetes Obes Metab 2004; 6: 367-374.
25. Wilhelmsen L, Rosengren A, Lappas G,. Hospitalizations for atrial fibrillation in the general male population: morbidity and risk factors. J Intern Med 2002; 250: 382-389.
26. Jeong JH,. Prevalence of and risk factors for atrial fibrillation in Korean adults older than 40 years. J Korean Med Sci 2005; 20: 26-30.
27. Zhou Z, Hu D,. An epidemiological study on the prevalence of atrial fibrillation in the Chinese population of mainland China. J Epidemiol Jpn Epidemiol Assoc 2008; 18: 209-216.
28. Wilhelmsen L, Rosengren A, Lappas G,. Hospitalizations for atrial fibrillation in the general male population: morbidity and risk factors. J Intern Med 2001; 250: 382-389.
29. Haïssaguerre M, Jaïs P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339: 659-666.
30. Moe GK, Abildskov JA,. Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge. Am Heart J 1959; 58: 59-70.
31. Aviles RJ, Martin DO, Apperson-Hansen C, et al. Inflammation as a risk factor for atrial fibrillation. Circulation 2003; 108: 3006-3010.
32. Chung MK, Martin DO, Sprecher D, et al. C-reactive protein elevation in patients with atrial arrhythmias inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001; 104: 2886-2891.
33. Engelmann MDM, Svendsen JH,. Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J 2005; 26: 2083-2092.
34. Picchi A, Capobianco S, Qiu T, et al. Coronary microvascular dysfunction in diabetes mellitus: A review. World J Cardiol 2010; 2: 377-390.
35. Kadappu KK, Boyd A, Eshoo S, et al. Changes in left atrial volume in diabetes mellitus: more than diastolic dysfunction? Eur Heart J-Cardiovasc Imaging 2012, pp. jes084-jes084.
36. Henry WL, Morganroth J, Pearlman AS, et al. Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation 1976; 53: 273-279.
37. Lee Y-S, Hyun DW, Jung BC, et al.KTK Cardiac Electrophysiology Working Group.,. Left atrial volume index as a predictor for occurrence of atrial fibrillation after ablation of typical atrial flutter. J Cardiol 2010; 56: 348-353.
38. Otake H, Suzuki H, Honda T, et al. Influences of autonomic nervous system on atrial arrhythmogenic substrates and the incidence of atrial fibrillation in diabetic heart. Int Heart J 2009; 50: 627-641.
39. Kildemoes HW, Sørensen HT, Hallas J,. The Danish National Prescription Registry. Scand J Public Health 2011; 39: 38-41.